Christopher Kelsey

Professor of Radiation Oncology
Christopher Kelsey


Clinical trials that are currently enrolling patients include a study investigating lower doses of radiation therapy for patients with diffuse large B-cell lymphoma, with the goal of maintaining excellent tumor control but decreasing the risk of long-term side effects of treatment.

I also have an interest in genetic determinants of radiation sensitivity, predictors of local recurrence after surgery for lung cancer, radiation-induced lung injury, and the role of radiation therapy in advanced (stage III-IV) diffuse large B-cell lymphoma and Hodgkin lymphoma.


Professor of Radiation Oncology in the School of Medicine

2020 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2017 School of Medicine


B.S. 1998

1998 Brigham Young University

M.D. 2002

2002 University of Colorado, Colorado Springs

Clinical Trials

Publications, Grants & Awards

DCI Centers, Cancer Types & Labs

Offices & Contact

30 Duke Medicine Circle, Room 05125A
Durham, NC
Radiation Oncology, Box 3085
Durham, NC